Fraser, Christopher,Kishimoto, Takashi Kei,Maldonado, Roberto A.
申请号：
AU2012249544
公开号：
AU2012249544A1
申请日:
2012.04.27
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+ T cell help specific to an antigen.
